EP3560490A4 - ORAL IBUPROFEN PREPARATION - Google Patents

ORAL IBUPROFEN PREPARATION Download PDF

Info

Publication number: EP3560490A4
Authority: EP; European Patent Office
Prior art keywords: oral ibuprofen; ibuprofen preparation; preparation; oral; ibuprofen
Prior art date: 2016-12-22
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

EP17883760.5A

Other languages

German (de)

French (fr)

Other versions

EP3560490A1 (en

EP3560490B1 (en

EP3560490C0 (en

Inventor

Tomihisa Yamaguchi

Makoto Umino

Nobuo Miyadai

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

SSP Co Ltd

Original Assignee

SSP Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2016-12-22

Filing date

2017-12-22

Publication date

2020-08-26

2017-12-22 Application filed by SSP Co Ltd filed Critical SSP Co Ltd

2019-10-30 Publication of EP3560490A1 publication Critical patent/EP3560490A1/en

2020-08-26 Publication of EP3560490A4 publication Critical patent/EP3560490A4/en

2024-11-06 Application granted granted Critical

2024-11-06 Publication of EP3560490B1 publication Critical patent/EP3560490B1/en

2024-11-06 Publication of EP3560490C0 publication Critical patent/EP3560490C0/en

Status Active legal-status Critical Current

2037-12-22 Anticipated expiration legal-status Critical

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/08—Oxides; Hydroxides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1611—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Inorganic Chemistry (AREA)
Molecular Biology (AREA)
Rheumatology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pain & Pain Management (AREA)
Biophysics (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

EP17883760.5A 2016-12-22 2017-12-22 Oral ibuprofen preparation Active EP3560490B1 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP2016249261A JP2018104299A (en)	2016-12-22	2016-12-22	Oral ibuprofen formulation
PCT/JP2017/046056 WO2018117249A1 (en)	2016-12-22	2017-12-22	Oral ibuprofen preparation

Publications (4)

Publication Number	Publication Date
EP3560490A1 EP3560490A1 (en)	2019-10-30
EP3560490A4 true EP3560490A4 (en)	2020-08-26
EP3560490B1 EP3560490B1 (en)	2024-11-06
EP3560490C0 EP3560490C0 (en)	2024-11-06

Family

ID=62626626

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP17883760.5A Active EP3560490B1 (en)	2016-12-22	2017-12-22	Oral ibuprofen preparation

Country Status (7)

Country	Link
EP (1)	EP3560490B1 (en)
JP (1)	JP2018104299A (en)
AU (1)	AU2017384442B2 (en)
HU (1)	HUE070029T2 (en)
MX (1)	MX2019007529A (en)
RU (1)	RU2751351C2 (en)
WO (1)	WO2018117249A1 (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0465235A1 (en) *	1990-07-03	1992-01-08	McNEIL-PPC, INC.	Pharmaceutical compositions and methods for alleviating gastrointestinal symptoms induced by nonsteroidal anti-inflammatory drugs

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2704721B2 (en) *	1987-02-12	1998-01-26	ライオン株式会社	Ibuprofen formulation
JPH01294619A (en) *	1988-02-16	1989-11-28	Sanwa Kagaku Kenkyusho Co Ltd	Glycyrrhetin preparation
JP3717189B2 (en) *	1992-01-27	2005-11-16	ダイト株式会社	Analgesic anti-inflammatory agent
JP2000264838A (en) *	1999-03-16	2000-09-26	Taiho Yakuhin Kogyo Kk	Processed ibuprofen powder and solid preparation containing it
JP5296968B2 (en) *	2005-06-17	2013-09-25	第一三共ヘルスケア株式会社	Oral pharmaceutical composition containing ibuprofen
JP2007084514A (en) *	2005-09-26	2007-04-05	Gunma Univ	Glycyrrhizin preparation for inflammatory bowel disease
JP2010270042A (en) *	2009-05-20	2010-12-02	Kowa Co	Method for stabilizing glycyrrhizic acid
JP5959393B2 (en) *	2012-09-27	2016-08-02	小林製薬株式会社	Pharmaceutical composition containing phenylpropionic acid anti-inflammatory analgesic
JP6117591B2 (en) *	2013-03-29	2017-04-19	小林製薬株式会社	Pharmaceutical composition containing mosapride and an antacid

2016
- 2016-12-22 JP JP2016249261A patent/JP2018104299A/en active Pending
2017
- 2017-12-22 MX MX2019007529A patent/MX2019007529A/en unknown
- 2017-12-22 HU HUE17883760A patent/HUE070029T2/en unknown
- 2017-12-22 AU AU2017384442A patent/AU2017384442B2/en active Active
- 2017-12-22 WO PCT/JP2017/046056 patent/WO2018117249A1/en not_active Ceased
- 2017-12-22 EP EP17883760.5A patent/EP3560490B1/en active Active
- 2017-12-22 RU RU2019122120A patent/RU2751351C2/en active

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0465235A1 (en) *	1990-07-03	1992-01-08	McNEIL-PPC, INC.	Pharmaceutical compositions and methods for alleviating gastrointestinal symptoms induced by nonsteroidal anti-inflammatory drugs

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
OKABE S ET AL: "Effects of Fm100, Fm 100-DeG and glycyrrhizin on gastric secretion and experimental gastriculcers in rats", OYO YAKURI - PHARMACOMETRICS, OYO YAKURI KENKYUKAI, JP, vol. 18, no. 3, 1 January 1979 (1979-01-01), pages 469 - 474, XP009521469, ISSN: 0300-8533 *

Also Published As

Publication number	Publication date
RU2019122120A3 (en)	2021-02-10
AU2017384442A1 (en)	2019-07-04
AU2017384442B2 (en)	2022-12-08
BR112019012932A2 (en)	2019-12-10
MX2019007529A (en)	2019-08-16
HUE070029T2 (en)	2025-05-28
EP3560490A1 (en)	2019-10-30
EP3560490B1 (en)	2024-11-06
EP3560490C0 (en)	2024-11-06
RU2019122120A (en)	2021-01-22
WO2018117249A1 (en)	2018-06-28
RU2751351C2 (en)	2021-07-13
JP2018104299A (en)	2018-07-05

Publication	Publication Date	Title
IL259419B (en)	2020-06-30	Oral care device
EP3297586C0 (en)	2025-04-09	ORAL DEVICE
EP3490539A4 (en)	2020-08-12	NEW ORAL FORMULATION
EP3643271C0 (en)	2023-06-07	ARC ADJUSTER
SI4070787T1 (en)	2023-07-31	PHARMACEUTICAL FORMULATIONS
DK3268067T3 (en)	2022-01-31	PHARMACEUTICAL ADMINISTRATIVE DEVICE
EP3405405C0 (en)	2025-01-15	ORAL HYDRATION SYSTEM
BR112017017199A2 (en)	2018-06-26	ORAL CARE IMPLEMENT
DK3199161T3 (en)	2022-01-03	Pharmaceutical preparation
BR112016027109A2 (en)	2018-07-10	oral hygiene implement
EP3603642A4 (en)	2020-09-02	PHARMACEUTICAL PREPARATION
DK3481420T3 (en)	2025-11-03	ANTIBODY FORMULATIONS
DK3436120T3 (en)	2023-09-25	Oral medical device
DK3373850T3 (en)	2022-03-07	IMPROVED MOUTH CLEANING DEVICE
EP3454847A4 (en)	2019-12-18	IMPROVED DRUG FORMULATIONS
EP3446684A4 (en)	2019-06-19	ORODISPERSIBLE TABLETS
EP3646866A4 (en)	2021-03-24	PHARMACEUTICAL PREPARATION
DK3280447T3 (en)	2019-05-13	PHARMACEUTICAL FORMULATIONS
HUE069648T2 (en)	2025-03-28	Pharmaceutical preparation
HUE051900T2 (en)	2021-03-29	Taste-masked oral pharmaceutical composition
BR112016025083A2 (en)	2018-07-10	oral care implement
IL252447B (en)	2020-11-30	Compound for oral care
HUE050881T2 (en)	2021-01-28	Pharmaceutical preparation
HUE066130T2 (en)	2024-07-28	Preparation containing Duddingtonia flagrans
KR20180084728A (en)	2018-07-25	Oral composition

Legal Events

Date	Code	Title	Description
2018-06-30	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE
2019-09-27	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2019-09-27	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE
2019-10-30	17P	Request for examination filed	Effective date: 20190717
2019-10-30	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
2019-10-30	AX	Request for extension of the european patent	Extension state: BA ME
2020-04-01	DAV	Request for validation of the european patent (deleted)
2020-04-01	DAX	Request for extension of the european patent (deleted)
2020-08-26	A4	Supplementary search report drawn up and despatched	Effective date: 20200724
2020-08-26	RIC1	Information provided on ipc code assigned before grant	Ipc: A61K 31/192 20060101AFI20200720BHEP Ipc: A61K 9/28 20060101ALI20200720BHEP Ipc: A61P 29/00 20060101ALI20200720BHEP Ipc: A61K 9/20 20060101ALI20200720BHEP Ipc: A61K 9/16 20060101ALI20200720BHEP Ipc: A61K 31/704 20060101ALI20200720BHEP
2023-11-24	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: EXAMINATION IS IN PROGRESS
2023-12-27	17Q	First examination report despatched	Effective date: 20231124
2024-06-06	GRAP	Despatch of communication of intention to grant a patent	Free format text: ORIGINAL CODE: EPIDOSNIGR1
2024-06-06	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: GRANT OF PATENT IS INTENDED
2024-07-03	INTG	Intention to grant announced	Effective date: 20240607
2024-10-01	GRAS	Grant fee paid	Free format text: ORIGINAL CODE: EPIDOSNIGR3
2024-10-03	GRAA	(expected) grant	Free format text: ORIGINAL CODE: 0009210
2024-10-03	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE PATENT HAS BEEN GRANTED
2024-11-06	AK	Designated contracting states	Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
2024-11-06	REG	Reference to a national code	Ref country code: GB Ref legal event code: FG4D
2024-11-15	REG	Reference to a national code	Ref country code: CH Ref legal event code: EP
2024-11-21	REG	Reference to a national code	Ref country code: DE Ref legal event code: R096 Ref document number: 602017086009 Country of ref document: DE
2024-12-04	REG	Reference to a national code	Ref country code: IE Ref legal event code: FG4D
2024-12-25	U01	Request for unitary effect filed	Effective date: 20241120
2025-01-01	U07	Unitary effect registered	Designated state(s): AT BE BG DE DK EE FI FR IT LT LU LV MT NL PT RO SE SI Effective date: 20241127
2025-02-05	U20	Renewal fee for the european patent with unitary effect paid	Year of fee payment: 8 Effective date: 20241227
2025-03-12	REG	Reference to a national code	Ref country code: SK Ref legal event code: T3 Ref document number: E 45817 Country of ref document: SK
2025-03-27	PGFP	Annual fee paid to national office [announced via postgrant information from national office to epo]	Ref country code: HU Payment date: 20241209 Year of fee payment: 8
2025-04-11	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20241106 Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20250306
2025-04-17	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20241106
2025-04-23	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20250206
2025-04-24	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20250207
2025-04-25	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20241106
2025-04-25	PGFP	Annual fee paid to national office [announced via postgrant information from national office to epo]	Ref country code: CZ Payment date: 20241209 Year of fee payment: 8
2025-04-28	PGFP	Annual fee paid to national office [announced via postgrant information from national office to epo]	Ref country code: SK Payment date: 20241203 Year of fee payment: 8
2025-04-29	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: RS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20250206
2025-05-28	REG	Reference to a national code	Ref country code: HU Ref legal event code: AG4A Ref document number: E070029 Country of ref document: HU
2025-07-03	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20241106
2025-07-31	REG	Reference to a national code	Ref country code: CH Ref legal event code: PL
2025-09-12	PLBE	No opposition filed within time limit	Free format text: ORIGINAL CODE: 0009261
2025-09-12	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT
2025-09-15	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20241106
2025-10-15	26N	No opposition filed	Effective date: 20250807
2025-10-21	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20241231
2025-10-22	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20241222
2025-10-29	GBPC	Gb: european patent ceased through non-payment of renewal fee	Effective date: 20250206
2025-11-19	U1N	Appointed representative for the unitary patent procedure changed after the registration of the unitary effect	Representative=s name: SANTARELLI; FR